In terms of anticancer activities, cardamonin inhibited the growth of cancer cells by regulating the cell cycle, promoting cell death, and targeting various signaling pathways, including the NF-κB signaling pathway [31,32,33]. The gene discussed is NFKB1; the disease is cancer.